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a  b  s  t  r  a  c  t
Huntington’s  disease  (HD)  is  a neurodegenerative  disorder,  characterized  by progressive  motor  and  non-
motor dysfunction  due  to  degeneration  of  medium  spiny  neurons  in  striatum.  3-Nitropropionic  acid  is
commonly  used  to  induce  the  animal  model  of  HD. Rice  bran  is supposed  to have  beneﬁcial  effects  on
mitochondrial  function.  The  present  study  has  been  designed  to explore  the  effect  of  rice bran  extract
against  3-Nitropropionic  acid induced  neurotoxicity  in  rats.  3-Nitropropionic  acid  (10  mg/kg,  i.p)  was
administered  systemically  for 21  days.  Hexane  and  ethanol  extract  of rice  bran were  prepared  using
Soxhlation.  Hexane  (250  mg/kg)  and ethanol  extract  (250  mg/kg)  were  administered  per os  for  21  days
in 3-NP  treated  groups.  Behavioral  parameters  (body  weight,  grip  strength,  motor  coordination,  locomo-
tion) were  conducted  on 7th,  14th  and  21st  day.  Animals  were  sacriﬁced  on  22nd  day  for biochemical,
mitochondrial  dysfunction  (Complex  II), neuroinﬂammatory  and  neurochemical  estimation  in  striatum.
This study  demonstrates  signiﬁcant  alteration  in  behavioral  parameters,  oxidative  burden  (increased
lipid  peroxidation,  nitrite  concentration  and  decreased  glutathione),  mitochondrial  function  (decreased
Complex  II enzyme  activity),  pro-inﬂammatory  mediators  and  neurochemical  levels  in  3-nitropropionic
acid  treated  animals.  Administration  of hexane  and  ethanol  extract  prevented  the  behavioral,  biochem-
ical,  neuroinﬂammatory  (increased  TNF-,  IL-1  and  IL-6)  and  neurochemical  alterations  (decreased
dopamine,  norepinephrine,  serotonin,  5-hydroxy  indole  acetic  acid,  GABA  and  increased  3,4-dihydro
phenyl  acetaldehyde,  homovanillic  acid and  glutamate  levels)  induced  by  3-nitropropionic  acid.  The  out-
comes of  present  study  suggest  that  rice  bran  extract  is beneﬁcial  and  might  emerge  as  an adjuvant  or
prophylactic  therapy  for  treatment  of  HD  like symptoms.
©  2015  Published  by  Elsevier  Ireland  Ltd.  This is an  open  access  article  under the CC  BY-NC-ND. Introduction
Huntington’s disease (HD) is a progressive and fatal neurode-
enerative disorder characterized by striatal speciﬁc degeneration
f GABA-ergic medium spiny neurons (MSNs) and associated with
otor, psychiatric and cognitive disturbances [1,2]. The exact
athogenic mechanism underlying HD has not been elucidated yet,
ut mitochondrial dysfunction, excitotoxicity, neuroinﬂammation,
xidative stress, neurochemical imbalance and apoptosis are most
ell accepted mechanisms [3,4]. Tetrabenazine is the only drug
hat has been approved by US FDA for treatment of chorea related
o HD [5]. Various toxins and genetic animal models are being used
or testing of novel and safe therapies.
∗ Corresponding author.
E-mail address: punnubansal79@gmail.com (P. Kumar).
ttp://dx.doi.org/10.1016/j.toxrep.2015.08.004
214-7500/© 2015 Published by Elsevier Ireland Ltd. This is an open access article under license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
3-NP is a mycotoxin, obtained from fungi and plants and is
widely used animal model for HD. It acts by irreversibly inhibi-
ting mitochondrial complex II (Succinate dehydrogenase) enzyme
of electron transport chain [6,7]. Intake of 3-NP in humans and
rodents produces motor abnormalities including dystonia, torsion
spasms, involuntary jerky movements, facial grimaces and cogni-
tive impairment [3]. 3-NP toxicity leads to diminution of adenosine
triphosphate (ATP) and energy depletion, altered calcium homeo-
stasis, excitotoxicity, free radical generation and neuronal death
[8].
Rice bran is the by-product of rice milling process and contains
about 10% of rough rice grain and 18–22% oil [9]. It mainly contains
-oryzanol, coumaric acid, ferulic acid, caffeic acid, phytic acid,
carotenoids, tocopherols, tocotrienols and phytosterols. Rice bran
has been found to beneﬁcial against inﬂammation, hyperlipidemia,
coronary heart disease, oxidative stress, cancer, type II diabetes,
Alzheimer’s disease and aging. Therefore, the present study was
intended to investigate the effect of rice bran extract against
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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-NP induced motor, behavior, biochemical, neuroinﬂammation
nd neurochemical alterations in rats.
. Material and methods
.1. Drugs and chemicals
3-NP was procured from Sigma–Aldrich, St. Louis, MO,  USA.
ice bran was collected from the rice mills (PUSA-44 rice vari-
ty) of Moga, Punjab, India. The voucher specimens were deposited
n the department of Pharmacognosy at our institute (specimen
umber HERB/COG/2014-15/1197/69). Interleukin-1 beta (IL-1),
nterleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-)  Kits
ere purchased from Krishgen Bio. Sys., Ashley ct Whittier, CA,
SA. Unless stated, all other chemicals and biochemical reagents
f highest analytical grade were used for the study.
.2. Extraction procedure
Fresh powder of rice bran was stabilized by sun drying to destroy
he enzyme lipase which causes development of free fatty acids
10]. The extracts (hexane and ethanol) of rice bran were prepared
sing Soxhlation process. Rice bran powder (500 g) was  taken and
ubjected to Soxhlation using hexane as solvent under temperature
0–80 ◦C. Further, the hexane extract was concentrated under vac-
um using rotary evaporator (Euitron Roteva, Media Instrument
fg. Co., Mumbai). The marc was then subjected to Soxhlation
sing ethanol as solvent under temperature 70–80 ◦C. The resul-
ant ethanolic extract was concentrated under vacuum using rotary
vaporator (Euitron Roteva, Media Instrument Mfg. Co., Mumbai).
.3. Standardization of rice bran extracts using HPLC
The presence of tocopherols was estimated by HPLC (Waters
tandard system) consisting of a gradient pump, a 20 l
njector valve, C18 reverse phase column and PDA detector.
ethanol–water (97:3% v/v) was used as solvent system. Column
emperature was maintained at 25 ◦C. Separation was carried out at
 ﬂow rate of 1.5 ml/min [11]. Samples (50 l) were being injected
utomatically. Hexane extract was dissolved in methanol and solu-
ion was ﬁltered through 0.22 m nylon ﬁlters before injecting in
he HPLC sample injector. Data were recorded and analyzed with
he help of Empower 2 software.
.4. Experimental animals
Adult male Wistar rats (3–4 months old), weighing 250–280 g
ere procured from central animal house of I.S.F. College of Phar-
acy, Moga, Punjab (India). The animals were housed in polyacrylic
ages in a well controlled atmosphere (room temperature 25 ± 1 ◦C
nd relative humidity of 60%) with 12 h light/dark cycle (lights
urned on at 7 AM). The animals were maintained on a commer-
ial food diet in the form of dry pellets and water ad libitum. All the
ehavioral parameters were assessed between 9:00 and 17:00 h.
he protocol of the study was approved by the Institutional Animal
thics Committee (IAEC) (Approval No. IAEC/CPCSEA/M14/P246)
nd was carried out in accordance with the Indian National Science
cademy (INSA) guidelines for the use and care of experimental
nimals. All the experiments for a given treatment were performed
sing age-matched animals in an effort to avoid variability between
xperimental groups..5. Acute oral toxicity test and dose selection
The acute oral toxicity and dose selection of hexane and
thanol extracts were conducted in female albino mice according torts 2 (2015) 1222–1232 1223
Organization for Economic Co-operation and Development (OECD)
425 guidelines (Acute Oral Toxicity – Up-and-Down Procedure;
OECD 425/2001). Animals were fasted 3–4 h prior to dosing. Hexane
and ethanol extracts were administered to animals in different dose
levels up to 5000 mg/kg by oral gavage. Animals were observed
daily for 14 days for clinical signs of toxicity including behavioral
changes, locomotion and mortality.
2.6. Experimental grouping
The experimental protocol was  divided into two  phases and con-
sists of six groups. The experimental protocol for the phase I and II
study is given below:
Phase I: In this phase, we  have evaluated the effect of ethanol
and hexane extract at medium dose and effect of both extracts was
compared. On the basis of this, we  found that hexane extract is
better in ameliorating the 3-NP induced neurotoxicity.
Group I: Vehicle treated group (Saline; i.p + CMC; p.o)
Group II: 3-NP (10 mg/kg; i.p) + CMC; p.o
Group III: 3-NP (10 mg/kg; i.p) + Ethanol extract (250 mg/kg; p.o)
Group IV: 3-NP (10 mg/kg; i.p) + Hexane extract (250 mg/kg; p.o)
Phase II: On the basis of results obtained in the phase I, testing of
high (500 mg/kg) and low dose (125 mg/kg) of hexane extract was
done.
Group V: 3-NP (10 mg/kg; i.p) + Hexane extract (125 mg/kg; p.o)
Group VI: 3-NP (10 mg/kg; i.p) + Hexane extract (500 mg/kg; p.o)
2.7. Treatment schedule
3-NP was  dissolved in normal saline (adjusted pH to 7.4) and
administered intraperitoneally (i.p) at a dose of 10 mg/kg for 21
days. Ethanol extract (250 mg/kg) and hexane extract (125, 250,
500 mg/kg) were suspended in 0.5% w/v  CMC  (carboxy methyl
cellulose) solution and administered per orally for 21 days in 3-
NP treated groups, one and half hour prior to 3-NP dosing. On 0,
7th, 14th, and 21st days, behavioral parameters like body weight,
narrow beam, grip strength, locomotor activity and motor coordi-
nation were assessed. On 22nd day, animals were sacriﬁced and
striatum was  isolated to carry out the evaluation of biochemical
[Lipid peroxidation (LPO), Glutathione (GSH), and nitrate], mito-
chondrial dysfunction (Complex II) and neurochemical [Dopamine
(DA), Nor-epinephrine (NE), 5-hydroxy tryptamine (5-HT), GABA,
glutamate and their metabolites] parameters. ELISA Kits were used
to estimate the levels of pro-inﬂammatory cytokines (IL-1, IL-6
and TNF-).
2.8. Measurement of body weight
Animal body weight was recorded on the ﬁrst and last days (21st
day) of experiment [12]. Percentage change in body weight was
calculated.
Change in Body Weight = Body Weight (1st day − 21st day)/Body
Weight (1st day) × 100
2.9. Behavioral assessment
2.9.1. Narrow beam walking test
Gait abnormalities and foot slips counts were measured by nar-
row beam walk apparatus. The animal was  made to walk on across a
narrow wooden beam. The beam consisted of two platforms (8 cm
in diameter) connected by a wooden beam (0.5 mm in thickness,
2.0 cm in width, and 120 cm in length). The beam was elevated
50 cm above ground. A box ﬁlled with sawdust was placed below
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he beam, serving as protection for a falling rat. Rat was allowed
o explore on elevated beam for 5 min  before training, so that rat
et adapt to it. A training trial was then begun by placing a rat on
he platform at one end. When a rat walked across the beam from
ne end to the other end, slipping of its feet occurred. Number of
lips and time taken to cross the beam in each trial was  recorded
13,14].
.9.2. Grip strength measurement
Grip strength of the fore limbs was measured using digital grip
orce meter (DFIS series, Chatillon, Greensboro, NC, USA). To mea-
ure forelimb grip strength, the rat was held by tail and lowered
oward the apparatus. The rat was positioned to grab the grid
ith the fore limbs and was gently pulled back to record the grip
trength. The grip strength was recorded in Kgf [15].
.9.3. Rotarod activity
Motor coordination and grip strength of rats was evaluated
sing rotarod apparatus (INCO Medicraft, Ambala, India). Before
ctual recording on rotarod apparatus, the animals were given
 prior training session for acclimatization on rotarod (constant
peed of 25 rpm; rod diameter 7 cm). The cut off time was 180 s
nd each rat performed three separate trials after a 5 min  gap. The
verage time of the fall was recorded [16,17].
.9.4. Open ﬁeld test
Open ﬁeld apparatus consist of wooden, rectangular, light
rown colored apparatus consisted of a square (100 × 100 cm) with
 surrounding wall (height: 40 cm). It was used to monitor locomo-
or activity of rats. The ﬂoor of the apparatus was  divided into 25
mall squares. A 40 watt white bulb was lit 150 cm above the test
pparatus and the room was illuminated. Before actual recording
n open ﬁeld apparatus, the animals were given a prior 15 min  time
o move freely for acclimatization. Two hours after the single expo-
ure of apparatus, the animal was placed in the center and number
f squares crossed/10 min, number of grooming/10 min  and num-
er of rearing/10 min  by the animal were recorded. Each crossing
as considered only when all the four paws of the animal were
n another square. After each trial, apparatus was cleaned prop-
rly. Total activity/10 min  were calculated by addition of number
f squares crossed, number of grooming and number of rearing by
he animal [18,19].
.10. Dissection and homogenization
On the 21st day, animals from each group were randomly
ivided into three sub-groups, one for biochemical estimations,
econd for neuroinﬂammatory markers estimation and third for
eurochemical estimation immediately after the behavioral assess-
ents. The brains were dissected out and placed on ice. Then the
triatum was separated and 10% (w/v) tissue homogenate was  pre-
ared in 0.1 M phosphate buffer (pH 7.4). The homogenate was
entrifuged at 10,000 g for 15 min. Aliquots of the supernatant was
eparated and used for biochemical estimation.
.11. Measurement of oxidative stress parameters
.11.1. Measurement of lipid peroxidation
The quantitative measurement of malondialdehyde (end prod-
ct of lipid peroxidation) in the brain striatum was performed
ccording to the method of [20]. The amount of malondialdehyde
MDA) was measured after its reaction with thiobarbituric acid at
32 nm using spectrophotometer (Shimadzu, UV-1700). The con-
entration of MDA  was expressed as n mol  per mg  protein.rts 2 (2015) 1222–1232
2.11.2. Estimation of nitrite
The accumulation of nitrite in the striatum supernatant, an
indicator of the production of nitric oxide, was determined by
a colorimetric assay with Greiss reagent [0.1% N-(1-naphthyl)
ethylenediame dihydrochloride, 1% sulphanilamide and 2.5% phos-
phoric acid] as described by [21]. Absorbance was measured at
540 nm using spectrophotometer (UV-1700, Shimadzu, Japan). The
concentration of nitrite was  expressed as mol  per mg protein.
2.11.3. Estimation of glutathione
The level of reduced glutathione in striatum of brain was esti-
mated according to the described method [22]. Absorbance was
measured at 412 nm using spectrophotometer (Shimadzu, UV-
1700). The concentration of glutathione was  expressed as mol
per mg  protein.
2.11.4. Protein estimation
The protein was  measured by the Lowry method using Folin
phenol reagent [23]. The phenolic group of tyrosine and trytophan
residues (amino acid) in a protein will produce a blue purple color
complex with Folin–Ciocalteu reagent which consists of sodium
tungstate molybdate and phosphate. Absorbance was measured at
660 nm using spectrophotometer (Shimadzu, UV-1700).
2.12. Mitochondrial complex estimation
2.12.1. Isolation of rat brain mitochondria
Rat brain mitochondria were isolated by the described method
[24]. The brain striatum was  homogenized in isolation buffer with
EGTA (215 mM mannitol, 75 mM sucrose, 0.1% Bovine serum albu-
min  (BSA), 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), 1 mM Ethylene glycol tetraacetic acid (EGTA), pH 7.2).
The homogenate was  centrifuged at 13,000 g for 5 min  at 4 ◦C. The
pellet was re-suspended in isolation buffer with EGTA and spun
again at 13,000 g for 5 min. The resulting supernatant was trans-
ferred to new tubes and topped off with isolation buffer containing
EGTA and spun again at 13,000 g for 10 min. The pellet containing
pure mitochondria was  re-suspended in isolation buffer without
EGTA.
2.12.2. Complex II (SDH activity)
Succinate dehydrogenase (SDH) was  measured spectrophoto-
metrically according to the described method by [25]. The method
involves the oxidation of succinate by an artiﬁcial electron accep-
tor, potassium ferricyanide. The reaction mixture contained 0.2 M
phosphate buffer pH 7.8, 1% BSA, 0.6 M succinic acid and 0.03 M
potassium ferricyanide. The reaction was  initiated by addition of
the striatum mitochondrial sample, and the absorbance change
at 420 nm was followed for 2 min  (protein concentration was
0.67 mg/ml).
2.13. Estimation of pro-inﬂammatory cytokines (IL-1ˇ,  IL-6 and
TNF-˛) levels
The quantiﬁcations of IL-1, IL-6 and TNF- were done by using
rat IL-1, IL-6 and TNF- immunoassay kit (KRISHGEN BioSys-
tems, Ashley ct Whittier, CA, USA). The quantikine rat IL-1,  IL-6
and TNF- immunoassay is a 4.5 h solid phase ELISA designed to
measure IL-1, IL-6 and TNF- levels. It is a solid-phase sandwich
enzyme linked immunosorbent assay (ELISA) using a microtitre
plate reader. Concentrations of proinﬂammatory cytokines were
calculated from the standard curves.
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.14. Neurochemical estimation
.14.1. Estimation of catecholamines
Catecholamines (DA, 5-HT and NE) and their metabolites [3,4-
ihydro phenyl acetaldehyde (DOPAC), 5-hydroxyindoleacetic acid
5-HIAA), homovanillic acid (HVA)] levels were estimated by HPLC
sing electrochemical detector. Waters standard system consisting
f a high pressure isocratic pump, a 20 l manual injector valve, C18
everse phase column and electrochemical detector were used in
he study. Mobile phase consisted of sodium citrate buffer (pH 4.5) –
cetonitrile (87:13), v/v). Sodium citrate buffer consisted of 10 mM
itric acid, 25 mM NaH2PO4, 25 mM ethylenediaminetetraacetic
cid (EDTA), and 2 mM of 1-heptane sulfonic acid. Electrochemical
onditions for the experiment were +0.75 V, sensitivity ranged from
 to 50 nA. Separation was carried out at a ﬂow rate of 0.8 ml/min.
amples (20 l) were injected manually. On the day of experiment
rozen brain samples were thawed and they were homogenized in
omogenizing solution containing 0.2 M perchloric acid. After that
amples were centrifuged at 12,000 g for 5 min. The supernatant
as ﬁltered through 0.22 m nylon ﬁlters before injecting in the
igh performance liquid chromatography (HPLC) sample injector
26]. Data were recorded and analyzed with the help of breeze
oftware. Concentrations of neurotransmitter and their metabo-
ites were calculated from the standard curve generated by using
tandard in a concentration range of 10–100 ng/ml.
.14.2. Estimation of GABA and glutamate
The estimation of GABA and glutamate was  done by method
escribed by Donzanti and Yamamoto [27] with slight modiﬁ-
ations. The mobile phase was comprised of 100 mM disodium
ydrogen phosphate anhydrous, 25 mM EDTA and 22% methanol
pH 6.5). Electrochemical conditions for the experiment were
0.65 V, sensitivity ranges from 5 to 50 nA. Separation was carried
ut at a ﬂow rate of 1.2 ml/min and column temperature was main-
ained at 40 ◦C. Samples (20 l) were injected manually through
heodyne valve injector. On the day of experiment frozen brain
amples were thawed and homogenized in 0.2 M perchloric acid.
fter that samples were centrifuged at 12,000 g for 15 min. The
upernatant was derivatized using OPA/-ME  and then ﬁltered
hrough 0.22 mm nylon ﬁlters before injecting into the HPLC sample
njector. Data were recorded and analyzed with the help of breeze
oftware. Concentrations of amino acids were calculated from the
tandard curve generated by using standard in a concentration
ange of 10–100 ng/ml. The values are expressed as percentage of
ormal Control group.
.14.3. Pre-column derivatisation procedure
Amino acids were measured as OPA/-ME  derivatives accord-
ng to the method of Donzanti and Yamamoto [27]. Stock solution
f amino acids standards were prepared at the level of 1 mg/ml.
tock solution of OPA/-ME  derivatizing reagent were prepared
y dissolving 27 mg  OPA in 1 ml  methanol. 5 l of -ME  and 9 ml
etraborate buffer (0.1 M Sodium tetraborate, pH 10.3) were then
dded. This solution is stable upto 5 days when protected from light.
he working OPA/-ME  derivatizing reagent was  prepared by dilut-
ng 2.5 ml  of stock OPA/ME solution with 7.5 ml  of tetraborate
uffer. This solution must be prepared fresh daily. Brain samples
ere derivatized by mixing sample and reagent in ratio of 1:1.5
sample:reagent ratio).
. Statistical analysisThe results are expressed as mean ± SD. The behavioral data
ere analyzed using two way analysis of variance (ANOVA)
ollowed by Bonferroni post hoc test for multiple comparison.
 < 0.005 was considered statistically signiﬁcant. For biochemicalrts 2 (2015) 1222–1232 1225
parameters, one way analysis of variance (ANOVA) followed by
Tukey’s post hoc test was  used for comparison. p < 0.05 was con-
sidered statistically signiﬁcant.
4. Results
HPLC results of both extracts revealed the presence of toco-
pherols (vitamin E) in hexane extract and absence of tocopherols
in ethanol extract.
Hexane and ethanol extracts of rice bran were prepared and
tested in 3-NP treated rats at dose of 250 mg/kg; p.o. In present
study, ﬁrstly we compared the results of hexane and ethanol extract
and found that hexane extract showed more promising effects as
compared to ethanol extract. Based on these ﬁndings we  further
preceded with lower (125 mg/kg; p.o) and higher doses (500 mg/kg;
p.o) of hexane extract and checked their activity in 3-NP treated
rats.
4.1. HPLC analysis of hexane extract and ethanol extract for
presence of tocopherols
HPLC of both extracts was performed to check the presence of
tocopherols using PDA detector (Fig. 1a and b). Only hexane extract
showed the presence of tocopherols.
4.2. Effect of rice bran extracts on 3-NP induced decrease in body
weight
There was no signiﬁcant change in initial and ﬁnal body weight
of normal control animals. 3-NP treatment (10 mg/kg/day; i.p)
caused a signiﬁcant (p < 0.001) gradual decrease in body weight
as compared to normal control group indicating development of
neurotoxicity. Pretreatment with hexane (250 mg/kg/day; p.o) and
ethanol extract (250 mg/kg/day; p.o) signiﬁcantly (p < 0.001) atten-
uated the fall in body weight as compared to 3-NP treated group.
Hexane extract (250 mg/kg/day; p.o) showed more signiﬁcant
(p < 0.05) effect as compared to ethanol extract (250 mg/kg/day;
p.o). On the basis of these results, lower (125 mg/kg/day; p.o) and
higher (500 mg/kg/day; p.o) doses of hexane extract were tested
in 3-NP treated rats. Hexane extract (125 and 500 mg/kg/day;
p.o) signiﬁcantly (p < 0.05) prevented fall in body weight in 3-
NP treated rats. The effect of hexane extract (500 mg/kg/day; p.o)
was more signiﬁcant (p < 0.05) as compared to hexane extract
(250 mg/kg/day; p.o) (Fig. 2).
4.3. Effect of rice bran extracts on narrow beam walk
performance in 3-NP treated rats
Systemic 3-NP (10 mg/kg/day; i.p) treatment produced signiﬁ-
cant (p < 0.01) gradual increase in transfer latency to cross narrow
beam runway and foot slips on narrow beam walk as compared
to normal control group (Figs. 3 and 4). Whereas, 3-NP adminis-
tered rats pretreated with hexane (250 mg/kg/day; p.o) and ethanol
extract (250 mg/kg/day; p.o) lead to signiﬁcant (p < 0.05) decrease
in transfer latency to cross beam and foot slips on narrow beam
walk as compared to 3-NP alone treated rats.
Further, hexane extract (125 and 500 mg/kg/day; p.o) signif-
icantly (p < 0.05) prevented increase in transfer latency to cross
beam and foot slips on narrow beam walk in 3-NP treated rats.
Hexane extract produced dose dependent effects. The effect of hex-
ane extract (500 mg/kg/day; p.o) was  more signiﬁcant (p < 0.05) as
compared to hexane extract (250 mg/kg/day; p.o).
1226 N. Kaur et al. / Toxicology Reports 2 (2015) 1222–1232
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.4. Effect of rice bran extracts on 3-NP induced changes in grip
trength performance, rotarod activity and locomotor activity
Systemic 3-NP (10 mg/kg/day; i.p) treatment produced signiﬁ-
ant (p < 0.001) gradual decrease in grip strength, rotarod activity
nd locomotor activity on 2nd (day 14th) and 3rd week (day
1st) as compared to normal control group (Figs. 5–7). Pre-
reatment with hexane extract (250 mg/kg/day; p.o) and ethanol
xtract (250 mg/kg/day; p.o) signiﬁcantly (p < 0.05) prevented the (a) and ethanol extract (b) using HPLC-PDA detector.
impairment in grip strength, rotarod activity and locomotor activity
as compared to 3-NP treated rats.
Hexane extract (125 mg/kg/day; p.o) showed no signiﬁcant
restoration of grip strength activity in 3-NP treated rats as com-
pared to 3-NP alone treated rats whereas it showed signiﬁcant
(p < 0.05) restoration of rotarod and locomotion activity in 3-NP
treated rats as compared 3-NP alone treated rats. On the other side,
hexane extract (500 mg/kg/day; p.o) signiﬁcantly (p < 0.001) pre-
vented decrease in grip strength, rotarod activity and locomotion
N. Kaur et al. / Toxicology Reports 2 (2015) 1222–1232 1227
Fig. 2. Effect of rice bran extracts on 3-NP induced decrease in body weight: data
e
(
H
a
T
n
p
4
g
c
a
p
e
p
c
t
F
t
(
n
Fig. 4. Effect of rice bran extracts on number of foot slips on narrow beam walkxpressed as mean ± SD: pa < 0.001 v/s Con, pb < 0.05 v/s 3-NP (10), pc < 0.05 v/s Eth
250), pd < 0.05 v/s Hex (250). Con = normal control; 3-NP = 3-nitropropionic acid;
ex = hexane; Eth = ethanol.
ctivity in 3-NP treated rats as compared 3-NP alone treated rats.
he effect of hexane extract (500 mg/kg/day; p.o) was  more sig-
iﬁcant (p < 0.05) as compared to hexane extract (250 mg/kg/day;
.o)
.5. Effect of rice bran extracts on lipid peroxidation, nitrite and
lutathione levels in 3-NP administered rats
Systemic administration of 3-NP (10 mg/kg/day; i.p) signiﬁ-
antly (p < 0.001) increased lipid peroxidation, nitrite concentration
nd depleted glutathione enzyme activity in the striatum as com-
ared to normal control group (Table 1). Pretreatment with hexane
xtract (250 mg/kg/day; p.o) and ethanol extract (250 mg/kg/day;
.o) signiﬁcantly (p < 0.05) attenuated lipid peroxidation, nitrite
oncentration and restored levels of antioxidant enzyme glu-
athione as compared to 3-NP alone treated group.
ig. 3. Effect of rice bran extracts on narrow beam walk transfer latency in 3-NP
reated rats: data expressed as mean ± SD: pa < 0.001 v/s Con, pb < 0.05 v/s 3-NP
10), pc < 0.05 v/s Eth (250), pd < 0.05 v/s Hex (250). Con = normal control; 3-NP = 3-
itropropionic acid; Hex = hexane; Eth = ethanol.apparatus in 3-NP treated rats: data expressed as mean ± SD: pa < 0.001 v/s Con,
pb < 0.05 v/s 3-NP (10), pc < 0.05 v/s Eth (250), pd < 0.05 v/s Hex (250). Con = normal
control; 3-NP = 3-nitropropionic acid; Hex = hexane; Eth = ethanol.
After that, hexane extract (125 mg/kg/day; p.o) showed no
signiﬁcant effect in preventing increase in nitrite concentration
whereas it signiﬁcantly (p < 0.05) attenuated lipid peroxidation
and showed signiﬁcant (p < 0.05) restoration of glutathione lev-
els as compared to 3-NP alone treated group. On the other hand,
hexane extract (500 mg/kg/day; p.o) signiﬁcantly (p < 0.05) attenu-
ated lipid peroxidation, nitrite concentration and restored levels of
antioxidant enzyme glutathione as compared to 3-NP alone treated
group. Effects produced by hexane extract (500 mg/kg/day; p.o) in
decreasing lipid peroxidation and nitrite concentration and restor-
ing glutathione levels were more signiﬁcant (p < 0.05) as compared
to hexane extract (250 mg/kg/day; p.o).
4.6. Effect of rice bran extracts on mitochondrial enzyme complex
II levels in 3-NP treated rats
Systemic administration of 3-NP (10 mg/kg/day; i.p) signiﬁ-
cantly (p < 0.001) impaired the mitochondrial enzyme complex II
Fig. 5. Effect of rice bran extracts on 3-NP induced changes in grip strength perfor-
mance: data expressed as mean ± SD: pa < 0.001 v/s Con, pb < 0.05 v/s 3-NP (10),
pc < 0.05 v/s Eth (250), pd < 0.05 v/s Hex (250). Con = normal control; 3-NP = 3-
nitropropionic acid; Hex = hexane; Eth = ethanol.
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Table  1
Effect of rice bran extracts on lipid peroxidation, glutathione and nitrite levels in 3-NP administered rats. Data expressed as mean ± SD: pa < 0.001 v/s Con, pb < 0.05 v/s 3-NP
(10),  pc < 0.05 v/s Eth (250), pd < 0.05 v/s Hex (250). Con = normal control; 3-NP = 3-nitropropionic acid; Hex = hexane; Eth = ethanol.
Treatment (mg/kg) MDA (n moles of MDA/mg protein) GSH ( moles of GSH/mg protein) Nitrite (g/ml)
Con 0.216 ± 0.136 0.0324 ± 0.0062 72.17 ± 23.57
3-NP  (10) 1.748 ± 0.108 a 0.0011 ± 0.0008 a 389.0 ± 47.25 a
Eth (250) 1.221 ± 0.220 b 0.0091 ± 0.0020 b 320.8 ± 30.52 b
Hex (250) 0.781 ± 0.184 b,c b,c b,c
Hex (125) 1.353 ± 0.366 b
Hex  (500) 0.402 ± 0.122 b,d
Fig. 6. Effect of rice bran extracts on 3-NP induced changes in rotarod activity: data
e
(
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axpressed as mean ± SD: pa < 0.001 v/s Con, pb < 0.05 v/s 3-NP (10), pc < 0.05 v/s Eth
250), pd < 0.05 v/s Hex (250). Con = normal control; 3-NP = 3-nitropropionic acid;
ex = hexane; Eth = ethanol.
ctivity as compared to normal control group (Fig. 8). Pretreat-
ent with hexane extract (250 mg/kg/day; p.o) and ethanol extract250 mg/kg/day; p.o) signiﬁcantly (p < 0.05) restored the mitochon-
rial enzyme complex II activity as compared to 3-NP treated group.
Hexane extract (125 mg/kg/day; p.o) showed no signiﬁcant
ffect in restoration of mitochondrial enzyme complex II activity
ig. 7. Effect of rice bran extracts on 3-NP induced changes in locomotor activity:
ata expressed as mean ± SD: pa < 0.001 v/s Con, pb < 0.05 v/s 3-NP (10), pc < 0.05
/s Eth (250), pd < 0.05 v/s Hex (250). Con = normal control; 3-NP = 3-nitropropionic
cid; Hex = hexane; Eth = ethanol.0.0180 ± 0.0052 182.8 ± 29.61
0.0088 ± 0.0013 356.0 ± 37.35
0.0273 ± 0.0057 b,d 106.3 ± 26.17 b,d
as compared to 3-NP alone treated group whereas, hexane extract
(500 mg/kg/day; p.o) signiﬁcantly (p < 0.05) and dose dependently
prevented impairment of mitochondrial complex II activity as com-
pared to 3-NP alone treated group and hexane extract (250 mg/kg;
p.o) treated group.
4.7. Effect of rice bran extracts on pro-inﬂammatory cytokines
(IL-1ˇ, IL-6 and TNF-˛) in 3-NP treated rats
Systemic 3-NP (10 mg/kg/day; i.p) treatment produced signif-
icant (p < 0.001) elevation in striatal IL-1, IL-6 and TNF- levels
as compared to normal control group. Pretreatment with hexane
extract (250 mg/kg/day; p.o) and ethanol extract (250 mg/kg/day;
p.o) signiﬁcantly (p < 0.05) attenuated the levels of IL-1, IL-6 and
TNF- in striatum as compared to 3-NP alone treated group. Hex-
ane extract (250 mg/kg/day; p.o) showed more signiﬁcant (p < 0.05)
and marked effects in attenuating the levels of IL-1, IL-6 and
TNF- in striatum as compared to ethanol extract (250 mg/kg/day;
p.o). On the basis of these results, lower (125 mg/kg/day; p.o) and
higher (500 mg/kg/day; p.o) doses of hexane extract were tested
in 3-NP treated rats. Hexane extract (125 mg/kg/day; p.o) and hex-
ane extract (500 mg/kg/day; p.o) signiﬁcantly (p < 0.05) and dose
dependently prevented increase in the levels of IL-1, IL-6 and
TNF- as compared to 3-NP alone treated group (Fig. 9).
4.8. Effect of rice bran extracts on brain catecholamines and their
metabolites levels in 3-NP treated rats
Systemic 3-NP (10 mg/kg/day; i.p) treatment caused signiﬁcant
(p < 0.001) decrease in levels of catecholamines (NE, DA and 5-HT)
and 5-HIAA in striatum and increase in levels of DOPAC and HVA
as compared to normal control group. Pretreatment with hexane
extract (250 mg/kg/day; p.o) and ethanol extract (250 mg/kg/day;
Fig. 8. Effect of rice bran extracts on mitochondrial enzyme complex II levels in 3-
NP  treated rats: data expressed as mean ± SD: pa < 0.001 v/s Con, pb < 0.05 v/s 3-NP
(10), pc < 0.05 v/s Eth (250), pd < 0.05 v/s Hex (250). Con = normal control; 3-NP = 3-
nitropropionic acid; Hex = hexane; Eth = ethanol.
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Fig. 9. Effect of rice bran extracts on pro-inﬂammatory cytokines (IL-1, IL-6 and
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Fig. 11. Effect of rice bran extracts on brain catecholamines metabolites levels inNF-) in 3-NP treated rats: data expressed as mean ± SD: pa < 0.001 v/s Con,
b < 0.05 v/s 3-NP (10), pc < 0.05 v/s Eth (250), pd < 0.05 v/s Hex (250). Con = normal
ontrol; 3-NP = 3-nitropropionic acid; Hex = hexane; Eth = ethanol.
.o) signiﬁcantly (p < 0.05) increased the levels of NE, DA, 5-HT and
-HIAA and decreased the levels of DOPAC and HVA as compared
o 3-NP alone treated group.
Hexane extract (125 and 500 mg/kg/day; p.o) signiﬁcantly
p < 0.05) prevented decrease in levels of NE, DA, 5-HT and 5-HIAA
nd increase in levels of DOPAC and HVA as compared to 3-NP
lone treated group. At last, hexane extract (500 mg/kg/day; p.o)
howed more signiﬁcant (p < 0.05) effect by attenuating decrease
n levels of NE, DA, 5-HT and 5-HIAA and increase in levels of
OPAC and HVA as compared to hexane extract (250 mg/kg/day;
.o) (Figs. 10 and 11).
.9. Effect of rice bran extracts on brain GABA and Glutamate
evels in 3-NP treated ratsSystemic 3-NP (10 mg/kg/day; i.p) treatment caused signif-
cant (p < 0.001) decrease in levels of GABA in striatum and
ncrease in levels glutamate as compared to normal control group.
ig. 10. Effect of rice bran extracts on brain catecholamines levels in 3-NP treated
ats:  data expressed as mean ± SD: pa < 0.001 v/s Con, pb < 0.05 v/s 3-NP (10), pc < 0.05
/s  Eth (250), pd < 0.05 v/s Hex (250). Con = normal control; 3-NP = 3-nitropropionic
cid; Hex = hexane; Eth = ethanol.3-NP  treated rats: data expressed as mean ± SD: pa < 0.001 v/s Con, pb < 0.05 v/s 3-NP
(10), pc < 0.05 v/s Eth (250), pd < 0.05 v/s Hex (250). Con = normal control; 3-NP = 3-
nitropropionic acid; Hex = hexane; Eth = ethanol.
Pretreatment with hexane extract (250 mg/kg/day; p.o) signiﬁ-
cantly (p < 0.05) increased the levels of GABA and decreased the
levels of glutamate, whereas pretreatment with ethanol extract
(250 mg/kg/day; p.o) did not show any signiﬁcant effect on levels
of GABA and glutamate as compared to 3-NP alone treated group.
Hexane extract (500 mg/kg/day; p.o) signiﬁcantly (p < 0.05) pre-
vented decrease in levels of GABA and increase in levels of, whereas
hexane extract (125 mg/kg; p.o) did not show any signiﬁcant effect
on levels of GABA and glutamate as compared to 3-NP alone treated
group. At last, hexane extract (500 mg/kg/day; p.o) showed more
signiﬁcant (p < 0.05) effect by attenuating decrease in levels of
GABA and increase in levels of glutamate as compared to hexane
extract (250 mg/kg/day; p.o) (Fig. 12).
5. DiscussionIn this study, we have investigated the role of rice bran extract
against 3-NP induced neurotoxicity. Rice bran extract is the by-
product of rice milling process. It contains a variety of components
including -oryzanol, coumaric acid, ferulic acid, caffeic acid, phytic
Fig. 12. Effect of rice bran extracts on brain GABA and Glutamate levels in 3-NP
treated rats: data expressed as mean ± SD: pa < 0.001 v/s Con, pb < 0.05 v/s 3-NP
(10), pc < 0.05 v/s Eth (250), pd < 0.05 v/s Hex (250). Con = normal control; 3-NP = 3-
nitropropionic acid; Hex = hexane; Eth = ethanol.
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cid; carotenoids such as - and -carotene, lutein, and lycopene,
eazanthin; the vitamin E isoforms , ,  and -tocopherol, and
ocotrienols; phytosterols such as b-sitosterol, campesterol and
tigmasterol [28]. Rice bran also contains pectin, cellulose, hemi-
elluloses, arabinoxylin; essential amino acids like tryptophan,
rginine, histidine, cysteine and methionine; and micronutrients
uch as phosphorous, magnesium, manganese, calcium and 9 B-
itamins [29]. Recently, rice bran has gained much attention, as
umerous studies have revealed the therapeutic potential against
xidative stress, cancer, type II diabetes, inﬂammation, hyper-
ipidemia, coronary heart disease, Alzheimer’s disease and aging
10,30]. Hexane and ethanol extracts of rice bran were prepared
sing Soxhlation and activity of both the extracts was tested at
ose of 250 mg/kg in 3-NP treated rats. Hexane extract showed sig-
iﬁcant and beneﬁcial effects as compared to ethanol extract at
50 mg/kg dose. Based on above ﬁndings, we further proceeded
ith lower (125 mg/kg) and higher (500 mg/kg) dose of 3-NP in
-NP treated group.
3-NP is a mitochondrial toxin which irreversibly inhibits the
itochondrial complex II enzyme (succinate dehydrogenase) and
cts as a gold standard model for induction of HD like symptoms in
ats. It has been reported that systemic administration of 3-NP imi-
ate all the pathophysiological features of HD like mitochondrial
ysfunction, excitotoxicity, oxidative stress as seen clinically and
roduced selective striatal degeneration leading to neurochemical
mbalance [31,32]. In present study, 3-NP was administered daily
or 21 days and produced signiﬁcant alteration in body weight,
rip strength, motor activity, biochemical parameters, mitochon-
rial enzyme complex II function, pro-inﬂammatory cytokines level
nd neurochemicals in rats. This impairment in locomotor activity,
otor functions and grip strength was due to selective degenera-
ion of GABAergic MSNs of striatum. Another trait of 3-NP induced
eurotoxicity is decrease in body weight, as observed in present
tudy, which might be due to energy defects and decrease in ATP
eneration in the body because of mitochondrial complex II inhi-
ition. The present ﬁndings are in harmony with earlier ﬁndings
ollowing 3-NP administration [33,34,31,35,36,12,32]. Pretreat-
ent with hexane extract signiﬁcantly prevented the alteration in
ody weight, grip strength, motor activity in the 3-NP treated ani-
als. This beneﬁcial effect may  be attributed to ability of hexane
xtract to prevent the alteration in the levels of catecholamines in
triatum [9].
Oxidative stress is considered as one of the chief determi-
ants of 3-NP induced neurotoxicity as evidenced by increased
xidative damage and diminution of endogenous antioxidant lev-
ls [34,17,15]. In the present study, 3-NP signiﬁcantly increased
he levels of MDA, nitrite and decreased the levels of glutathione
ntioxidant enzyme in the striatum. Reports from literature indi-
ate that 3-NP toxicity leads to depletion of ATP and energy failure,
ltered calcium homeostasis, excitotoxic events, increased reactive
xygen species (ROS) production. ROS production in turn leads to
mbalance between oxidants/antioxidants, causing molecular dam-
ge that leads to neuronal cell death [6]. In the present study,
re-treatment with hexane extract signiﬁcantly reversed the 3-NP
nduced oxidative stress. Reports have shown that hexane extract of
ice bran contains tocopherols and tocotrienols, well known antiox-
dants, contributing to the beneﬁcial effects of this extract against
xidative stress [37,38]. HPLC results from our lab also proved that
exane extract contains tocopherols and tocotrienols.
Mitochondria are membrane bound organelle, also known as
cellular power plants” because they generate most of the cell’s sup-
ly of ATP. In addition to supplying cellular energy, mitochondria
re involved in signaling, cellular differentiation, cell death, control
f the cell cycle and cell growth. In the present study, 3-NP irre-
ersibly inhibited the enzyme succinate dehydrogenase, which is a
ember of the Krebs tricarboxylic acid cycle (oxidizing succinaterts 2 (2015) 1222–1232
to fumarate). This inhibition in turn is associated with generation
of ROS. These ﬁndings are analogous to previous reports [31,12,39].
Pretreatment with hexane extract of rice bran at higher dose sig-
niﬁcantly prevented the 3-NP induced alteration in mitochondrial
enzyme complex II activity in striatum suggesting protective role
of hexane extract against mitochondrial dysfunction. Also, the hex-
ane extract of rice bran have been reported to have beneﬁcial effect
against mitochondrial dysfunction in Alzheimer disease in previous
studies. According to previous reports, hexane extract improved
mitochondrial function by increasing mitochondrial membrane
potential, ATP levels, complex I and II activity [40,30].
Neuroinﬂammation is increasingly being known as a biologi-
cal process that resembles pathological cascades underlying HD in
a very close manner. Pro-inﬂammatory cytokines such as IL-1,
IL-6 and TNF- have been implicated in the pathogenesis of var-
ious neurodegenerative diseases [41]. In the current study, 3-NP
lead to signiﬁcant increase in the levels of IL-1, IL-6 and TNF-
in striatum as compared to normal control group, as documented
in previous studies [15]. Previous literature suggests that in HD,
neuroinﬂammation mediated by cytokines and nitric oxide (NO)
ﬁnally contributes to excitotoxicity, mitochondrial dysfunction and
neurodegeneration [42]. Pretreatment with hexane extract sig-
niﬁcantly prevented this increase in levels of pro-inﬂammatory
cytokines (IL-1, IL-6 and TNF-). Previous reports from literature
showed that tocopherols, tocotrienols and -oryzanol present in
rice bran oil have protective effect against neuroinﬂammation and
have free radical scavenging property [43].
Neurochemical imbalance is well reported to occur in HD. In the
present study 3-NP administration caused signiﬁcant decrease in
the levels of catecholamines (NE, DA and 5-HT), 5-HIAA and GABA
and increase in the levels of DOPAC, HVA and glutamate in the
striatum as compared to normal control group. The results are in
tune with the previous reports [3]. In HD, previous ﬁndings sug-
gest that biphasic changes in dopamine neurotransmission occur.
In the early stages the neurotransmission of DA increases and leads
to hyperkinesia which can be controlled by depletion of dopamine
stores but on the other hand, neurotransmission of DA decreases
and lead to hypokinesia in later stages of disease which can be
controlled by increasing DA function [48]. The levels of serotonin
(5-HT) and its metabolite (5-HIAA) are also found to be decreased
in HD [47]. In the striatum, 90% of neurons are medium spiny neu-
rons; GABA-containing projection neurons are preferentially lost in
HD [44]. The loss of striatal GABA receptors probably represents the
loss of striatal neurons. Pretreatment with hexane extract signiﬁ-
cantly corrected this imbalance in levels of catecholamines (NE, DA,
5-HT), their metabolites (HVA, DOPAC, 5-HIAA), GABA and gluta-
mate. Reports from previous studies showed that hexane extract of
rice bran containing -oryzanol, tocopherols and tocotrienols nor-
malizes the level of striatal neurotransmitters (NE, DA  and 5-HT)
[9]. Previous reports have also elucidated the effects of vitamin E in
protecting astrocytes against glutamate injury [45]. Another report
form literature have concluded that production of GABA by Lacto-
bacillus sakei B2-16 increases in the presence of rice bran extract
[46].
Rice bran is one of the co-products of rice milling process. In
the last few years, it has been emerging as a therapeutic agent in
various disease conditions. Reports show that rice bran is a potent
antioxidant. It contains many natural antioxidants like tocopherols,
tocotrienols, oryzanols and ferulic acid esters [10,37]. Reports from
the literature suggest that rice bran protective affect against com-
plex I and complex II of mitochondria. It has been reported that
rice bran improves the mitochondrial activity in cellular model of
early Alzheimer’s disease [40,30]. Rice bran components like con-
taining -oryzanol, tocopherols and tocotrienols are well reported
to increase the levels of catecholamines (NE, DA and 5-HT) [9].
Moreover, rice bran is reported to enhance the production of GABA
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y Lactobacillus sakei B2-16 [46]. Rice bran contains tocopherols
nd tocotrienols which are protective against excitotoxicity. In the
tudy conducted by Selvaraju and co-workers, the effects of vita-
in  E (TRF and -TCP) in protecting astrocytes against glutamate
njury were elucidated. Hence, vitamin E acted as a potent antiox-
dant agent in recovering mitochondrial injury due to elevated
xidative stress, and enhanced better survivability upon gluta-
ate toxicity [45]. Hence, normalization of the level of striatal
eurotransmitters can be considered as key factor contributing to
he beneﬁcial effect of rice bran. Rice bran constituents like toco-
herols, tocotrienols and oryzanols have been reported to exhibit
rotective effect against neuroinﬂammation and moreover, act as
ree radical scavengers also [43].
. Conclusion
Results obtained from the current study suggested that hexane
xtract of rice bran showed more beneﬁcial effect as compared
o ethanol extract and out of three different doses (125, 250 and
00 mg/kg) of hexane extract, higher dose (500 mg/kg) produced
ore pronounced effect in ameliorating the 3-NP induced neu-
otoxicity in rats. The neuroprotective efﬁcacy of hexane extract
an be attributed to presence of tocopherols, tocotrienols and
-oryzanols which have protective effect against mitochondrial
ysfunction, oxidative stress, excitotoxicity, neuroinﬂammation
nd neurochemical alteration. The outcomes of the present study
uggest that hexane extract of rice bran extract is beneﬁcial and
herefore might emerge as an adjuvant or prophylactic therapy for
reatment of HD like symptoms.
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